Home/Filings/4/0001209191-10-010686
4//SEC Filing

Feeney John Joseph 4

Accession 0001209191-10-010686

CIK 0001347178other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 11:25 AM ET

Size

7.4 KB

Accession

0001209191-10-010686

Insider Transaction Report

Form 4
Period: 2010-02-18
Feeney John Joseph
Acting Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2010-02-18+20,00020,000 total
  • Exercise/Conversion

    Restricted Stock Units

    2010-02-1820,0000 total
    Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]The Restricted Stock Units represented a contingent right to receive a share of the Issuer's common stock which vested on December 31, 2009.
  • [F2]N/A

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001454240

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 11:25 AM ET
Size
7.4 KB